Table 2.
Clinical categorical variables related to SRL response.
Group | SRL responsea | Pearson χ2 p-valueb | |||
---|---|---|---|---|---|
CR | PR | NR | |||
Presurgical hypopituitarism | Yes | 42% | 15% | 55% | 0.01 |
No | 68% | 85% | 45% | ||
Presurgical visual alterations | Yes | 13% | 27% | 19% | 0.62 |
No | 87% | 73% | 81% | ||
T2 signal intensity | Hypointense | 31% | 22% | 36% | 0.90 |
Isointense | 38% | 56% | 36% | ||
Hyperintense | 31% | 22% | 28% | ||
T1 signal intensity | Hypointense | 61% | 40% | 53% | 0.75 |
Isointense | 39% | 50% | 38% | ||
Hyperintense | 0% | 10% | 8% | ||
Gender | Male | 46% | 35% | 62% | 0.07 |
Female | 54% | 65% | 38% | ||
GNAS mutation | Mutated | 29% | 38% | 36% | 0.83 |
WT | 71% | 62% | 64% | ||
Sinus Invasion | Yes | 22% | 35% | 59% | 0.05 |
No | 78% | 65% | 41% | ||
Extrasellar growth | Yes | 48% | 60% | 95% | 0.004 |
No | 52% | 40% | 5% |
aSRL response columns indicate the percentage of patients with CR, PR, or NR dictated by the presence of absence of the clinical condition.
bPearson χ2 p-values are shown. Statistically significant values (p-value < 0.05) are reported in bold.